Testing proposed quality measures for treatment of carpal tunnel syndrome: feasibility, magnitude of quality gaps, and reliability.
Alex H S HarrisEsther L MeerwijkQian DingAmber W TrickeyAndrea K FinlayEric M SchmidtCatherine M CurtinErika D SearsTeryl K NuckolsRobin N KamalPublished in: BMC health services research (2020)
Measure 3 displayed adequate facility- and surgeon-level variability and reliability to justify its use for quality monitoring and improvement purposes. Measures 1 and 2 lacked quality gaps, suggesting they should not be implemented in VA and need to be tested in other healthcare settings. Opportunities exist to refine the specifications of Measure 3 to ensure that different organizations calculate the measure in the same way.